Mini Review
Published: 28 September, 2017 | Volume 1 - Issue 1 | Pages: 023-027
Chemotherapy is one of the main treatment options for cancer. However, chemotherapeutic agents usually suffer from poor pharmaceutical properties that restrict their use. Targeted therapy drugs have been developed to specifically target changes in cancer cells that help these cells to grow. Such drugs often work when standard chemotherapeutic drugs do not, they often have less severe side effects and they are most often used for advanced cancers. The objective of this article is to give an overview about the 16 FDA-approved targeted therapy drugs to treat non-small cell lung cancer.
Read Full Article HTML DOI: 10.29328/journal.jprr.1001005 Cite this Article Read Full Article PDF